BACKGROUND: Preoperative blood transfusion has had a significant historic impact on graft outcome in clinical kidney transplantation, and the effect has been widely replicated in many experimental transplant models. Although the mechanisms underlying the blood-transfusion effect are poorly understood, one possibility is that preexposure to alloantigen results in the induction of regulatory cells with the capacity to control the effector arm of the immune response. METHODS: Recent studies in autoimmune models have shown that T cells with regulatory function can be isolated from unmanipulated animals on the basis of CD25 expression, and we have recently shown that pretreatment of recipient mice with donor alloantigen combined with anti-CD4 an...
International audienceThe contribution of natural CD4(+)CD25(+) regulatory T cells (nTregs) in contr...
BACKGROUND: Treatment with anti-CD154 monoclonal antibody (mAb) plus a donor-specific transfusion (D...
BACKGROUND: Treatment with anti-CD154 monoclonal antibody (mAb) plus a donor-specific transfusion (D...
The importance of CD25(+)CD4(+) regulatory T (Treg) cells in the control of immune responses is esta...
Clinical transplantation continues to rely on the use of non-specific immunosuppressive therapy, whi...
BACKGROUND: CD25+CD4+ regulatory T cells have been shown to suppress alloimmunity in various experim...
International audienceThymus-derived regulatory T lymphocytes of CD4(+)CD25(+) phenotype regulate a ...
The capacity of naturally occurring autoreactive CD25+CD4+ regulatory T cells (Treg) to control immu...
Background. In the search for mechanisms that can induce and maintain transplant tolerance, donor-sp...
Induction of transplantation tolerance to alloantigens without general immunosup-pression remains an...
To investigate the antigen specificity of regulatory T cells capable of preventing transplant reject...
Current therapies in transplantation require continuous immunosuppression and do not result in trans...
Allogeneic bone marrow transplantation is a potentially curative treatment for both inherited and ac...
Purpose: The mechanisms by which CD4+CD25+Foxp3+ T cells (Tregs) regulate effector T cells in a tran...
BACKGROUND: Allografts are occasionally accepted in the absence of immunosuppression. Because natura...
International audienceThe contribution of natural CD4(+)CD25(+) regulatory T cells (nTregs) in contr...
BACKGROUND: Treatment with anti-CD154 monoclonal antibody (mAb) plus a donor-specific transfusion (D...
BACKGROUND: Treatment with anti-CD154 monoclonal antibody (mAb) plus a donor-specific transfusion (D...
The importance of CD25(+)CD4(+) regulatory T (Treg) cells in the control of immune responses is esta...
Clinical transplantation continues to rely on the use of non-specific immunosuppressive therapy, whi...
BACKGROUND: CD25+CD4+ regulatory T cells have been shown to suppress alloimmunity in various experim...
International audienceThymus-derived regulatory T lymphocytes of CD4(+)CD25(+) phenotype regulate a ...
The capacity of naturally occurring autoreactive CD25+CD4+ regulatory T cells (Treg) to control immu...
Background. In the search for mechanisms that can induce and maintain transplant tolerance, donor-sp...
Induction of transplantation tolerance to alloantigens without general immunosup-pression remains an...
To investigate the antigen specificity of regulatory T cells capable of preventing transplant reject...
Current therapies in transplantation require continuous immunosuppression and do not result in trans...
Allogeneic bone marrow transplantation is a potentially curative treatment for both inherited and ac...
Purpose: The mechanisms by which CD4+CD25+Foxp3+ T cells (Tregs) regulate effector T cells in a tran...
BACKGROUND: Allografts are occasionally accepted in the absence of immunosuppression. Because natura...
International audienceThe contribution of natural CD4(+)CD25(+) regulatory T cells (nTregs) in contr...
BACKGROUND: Treatment with anti-CD154 monoclonal antibody (mAb) plus a donor-specific transfusion (D...
BACKGROUND: Treatment with anti-CD154 monoclonal antibody (mAb) plus a donor-specific transfusion (D...